PGIM Jennison Health Sciences Fund - Class C (PHLCX)
Fund Assets | 1.68B |
Expense Ratio | 1.96% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 5.25 |
Dividend Yield | 45.31% |
Dividend Growth | 174.48% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 20, 2024 |
Previous Close | 11.59 |
YTD Return | -9.11% |
1-Year Return | -0.49% |
5-Year Return | 46.48% |
52-Week Low | 10.87 |
52-Week High | 19.91 |
Beta (5Y) | 0.58 |
Holdings | 47 |
Inception Date | Jun 30, 1999 |
About PHLCX
The Fund's investment strategy focuses on Health/Biotech with 1.85% total expense ratio. The minimum amount to invest in Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class C Shares is $1,000 on a standard taxable account. Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class C Shares seeks long-term capital appreciation. PHLCX invests primarily in equity-related securities of U.S. firms engaged in the following industries: hospitals, nursing and residential care, health and medical insurance carriers, pharmaceutical and medicine companies, and medical equipment firms.
Performance
PHLCX had a total return of -0.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.78%.
Top 10 Holdings
57.68% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 16.38% |
Prudential Govt Money Mkt Fd | n/a | 7.81% |
Vertex Pharmaceuticals Incorporated | VRTX | 5.26% |
argenx SE | ARGX | 5.02% |
UnitedHealth Group Incorporated | UNH | 4.59% |
Thermo Fisher Scientific Inc. | TMO | 4.26% |
AstraZeneca PLC | AZN | 4.21% |
Neurocrine Biosciences, Inc. | NBIX | 3.70% |
CVS Health Corporation | CVS | 3.37% |
Danaher Corporation | DHR | 3.08% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 20, 2024 | $5.25148 | Dec 20, 2024 |
Dec 20, 2023 | $1.91322 | Dec 20, 2023 |
Dec 20, 2022 | $0.61624 | Dec 20, 2022 |
Dec 20, 2021 | $14.02528 | Dec 20, 2021 |
Dec 20, 2019 | $1.43164 | Dec 20, 2019 |
Dec 20, 2018 | $4.77761 | Dec 20, 2018 |